Why Us?

Common IssueS and Challenges

  • How do you overcome the problem of lack of internal market access experience and resource?
  • Are you able to launch products effectively and optimize market access (including HTAs) in a rapidly changing and complex healthcare environment in UK and Europe?
  • When should you be developing a market access strategy for your product?
  • Do you know what market access activities need to be undertaken to launch effectively and what will be a waste of time and effort?
  • Do you need insights or support on market access issues as part of a due diligence exercise?

How Do We Make it Work?

  • An initial introductory meeting to discuss the issues
  • A 2-5 day review with Action Plan and next steps proposal
  • Follow-up client meeting to discuss proposal and options
  • Work with client to implement suggested action plan
  • Optional, ongoing support to your team in terms of implementation review


  • Bespoke, market access solutions for individual products
  • Extensive contacts in HTA environment and pharmaceutical industry
  • Proven track record with UK and Ireland HTA bodies
  • Flexible approach according to company and investor needs (1-2 days per week/ 2-4 days per month)